VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AEG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AEGAegon Ltd.
$8.75$13.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAEGQuarterly Financials

Aegon Ltd. (AEG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Aegon Ltd. (AEG) quarterly income statement — complete revenue, gross profit & net income history

AEG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q2'25Q4'24Q2'24Q1'24Q4'23Q3'23Q2'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20Q2'20Q4'19Q3'19
Revenue19B6.65B16.29B3.23B3.23B3.11B3.11B6.24B20.56B-3.9B-23.27B-8.68B14.91B6.27B17.5B8.61B23.52B30.63B12.47B12.09B
Revenue Growth %16.59%106.23%424.06%-48.26%--84.88%179.8%126.8%37.83%-162.15%-232.94%-200.79%-36.58%--42.85%-88.65%52.3%2889.45%3203.55%
Medical Costs & Claims0000000000001.72B-559M001.76B000
Medical Cost Ratio %0%0%0%0%0%0%0%0%0%0%0%0%11.52%-8.92%0%0%7.5%0%0%0%
Gross Profit19B6.65B16.29B3.23B3.23B3.11B3.11B6.24B20.56B-3.9B-23.27B-8.68B13.2B6.83B17.5B8.61B21.75B30.63B12.47B12.09B
Gross Margin %100%100%100%100%100%100%100%100%100%100%100%100%88.48%108.92%100%100%92.5%100%100%100%
Gross Profit Growth %16.59%106.23%424.06%-48.26%--84.88%179.8%126.8%55.78%-157.06%-232.94%-200.79%-39.34%--42.85%-74.51%52.3%2889.45%3203.55%
Operating Expenses18.63B249M18.71B153M153M157.5M3.1B-6.27B-22.04B3.7B22.89B9.11B-12.1B-6.88B-16.39B-8.07B-21.54B-31.91B11.4B11.4B
OpEx / Revenue %98.08%3.74%114.83%4.74%4.74%5.07%99.69%-100.59%-107.19%-94.97%-98.4%-104.93%-81.15%-109.83%-93.66%-93.74%-91.61%-104.21%91.48%94.32%
Depreciation & Amortization-97.91M-79.73M-107.5M76.5M092.5M92.5M263M164M259M279M330M136M596M161M274M218M332M33M-458M
Combined Ratio %98.08%3.74%114.83%4.74%4.74%5.07%99.69%-100.59%-107.19%-94.97%-98.4%-104.93%-69.63%-118.74%-93.66%-93.74%-84.11%-104.21%91.48%94.32%
Operating Income365.28M6.4B-2.42B3.07B3.07B2.95B-92.5M-37M-1.48B-196M-373M428M1.09B-57M1.11B539M210M-1.29B833M458M
Operating Margin %1.92%96.26%-14.83%95.26%95.26%94.93%-2.98%-0.59%-7.19%5.03%1.6%-4.93%7.33%-0.91%6.34%6.26%0.89%-4.21%6.68%3.79%
Operating Income Growth %115.12%108.4%-181.86%8405.41%-299.56%52.81%90.08%-235.32%-243.86%-133.6%-20.59%420.48%-186.11%--74.79%-629.36%214.93%158.03%
EBITDA267.37M6.32B-2.52B3.15B3.15B3.04B0226M-1.31B63M-94M758M1.23B539M1.27B813M428M-957M866M0
EBITDA Margin %1.41%95.06%-15.49%97.63%97.63%97.91%0%3.62%-6.4%-1.62%0.4%-8.73%8.24%8.6%7.26%9.44%1.82%-3.12%6.95%0%
Interest Expense159.81M176M6M237.79M0-99M0106M32M117M98M82M81M87M83M84M126M115M00
Non-Operating Income-159.81M-192.22M3.06B-3.07B-3.07B-2.95B-2.95B285M1.11B202M-17M-455M-1.11B37M-1.12B-542M-219M1.29B-11.16B-10.79B
Pretax Income365.28M677M795M-67.5M-67.5M-102.5M-102.5M-391M-1.14B-319M-454M373M1.03B-124M1.03B458M93M-1.4B927M552M
Pretax Margin %1.92%10.18%4.88%-2.09%-2.09%-3.3%-3.3%-6.27%-5.56%8.19%1.95%-4.3%6.93%-1.98%5.91%5.32%0.4%-4.58%7.44%4.57%
Income Tax-5.96M72M54M70M-35M140M-70M-104M-259M-113M-106M-39M179M-65M185M72M13M-335M170M84M
Effective Tax Rate %-1.63%10.64%6.79%-103.7%51.85%-136.59%68.29%26.6%22.66%35.42%23.35%-10.46%17.33%52.42%17.89%15.72%13.98%23.88%18.34%15.22%
Net Income389.1M584M714M-26M-26M11M-33.5M67M-884M-206M-348M382M820M-79M828M375M57M-1.07B737M448M
Net Margin %2.05%8.78%4.38%-0.81%-0.81%0.35%-1.08%1.07%-4.3%5.29%1.5%-4.4%5.5%-1.26%4.73%4.35%0.24%-3.49%5.91%3.71%
Net Income Growth %-45.5%2346.15%6390.91%-138.81%-101.24%83.74%119.25%-207.8%-160.76%-142.03%1.87%1338.6%-177.46%--92.27%-951.79%821.25%433.33%
EPS (Diluted)0.260.360.33-0.03-0.02-0.04-0.020.03-0.45-0.08-0.140.150.32-0.030.400.180.03-0.410.360.22
EPS Growth %-21.21%1423.53%1004.11%-190.67%-91.89%77.35%121.43%-240.63%-166.67%-135%-16.67%1085.19%-197.56%--92.5%-959.54%825.45%437.9%
EPS (Basic)0.260.360.42-0.05-0.03-0.04-0.020.03-0.45-0.08-0.140.150.32-0.030.400.180.03-0.410.360.22
Diluted Shares Outstanding1.51B1.58B2.01B1.67B1.67B1.75B1.84B2.23B1.98B2.55B2.55B2.56B2.56B2.61B2.61B2.6B2.6B2.6B2.06B2.06B